OA11087A - Pharmaceutical formulations comprising amoxocyllinand clavulanate - Google Patents

Pharmaceutical formulations comprising amoxocyllinand clavulanate Download PDF

Info

Publication number
OA11087A
OA11087A OA9900181A OA9900181A OA11087A OA 11087 A OA11087 A OA 11087A OA 9900181 A OA9900181 A OA 9900181A OA 9900181 A OA9900181 A OA 9900181A OA 11087 A OA11087 A OA 11087A
Authority
OA
OAPI
Prior art keywords
amoxycillin
clavulanate
granulates
tablet
formulation
Prior art date
Application number
OA9900181A
Other languages
English (en)
Inventor
Jacky Andre Gustave Mention
Jose Luis Sanroma Bordallo
Kevin Huntley Storm
Original Assignee
Smithkline Beecham Lab
Smithkline Beecham Sa
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703100.9A external-priority patent/GB9703100D0/en
Priority claimed from GBGB9703099.3A external-priority patent/GB9703099D0/en
Priority claimed from GBGB9703101.7A external-priority patent/GB9703101D0/en
Application filed by Smithkline Beecham Lab, Smithkline Beecham Sa, Smithkline Beecham Corp filed Critical Smithkline Beecham Lab
Publication of OA11087A publication Critical patent/OA11087A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
OA9900181A 1997-02-14 1999-08-13 Pharmaceutical formulations comprising amoxocyllinand clavulanate OA11087A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9703100.9A GB9703100D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703099.3A GB9703099D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703101.7A GB9703101D0 (en) 1997-02-14 1997-02-14 Formulations

Publications (1)

Publication Number Publication Date
OA11087A true OA11087A (en) 2003-03-13

Family

ID=27268719

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900181A OA11087A (en) 1997-02-14 1999-08-13 Pharmaceutical formulations comprising amoxocyllinand clavulanate

Country Status (25)

Country Link
EP (2) EP0975342B1 (fr)
JP (1) JP2001512451A (fr)
KR (1) KR100499812B1 (fr)
CN (1) CN1194687C (fr)
AP (1) AP1253A (fr)
AT (1) ATE243516T1 (fr)
AU (1) AU728526B2 (fr)
BG (1) BG103664A (fr)
BR (1) BR9807383A (fr)
CA (1) CA2280857A1 (fr)
DE (1) DE69815833T2 (fr)
DZ (1) DZ2420A1 (fr)
EA (1) EA002595B1 (fr)
ES (1) ES2201468T3 (fr)
HK (1) HK1043041A1 (fr)
ID (1) ID23673A (fr)
IL (1) IL131201A (fr)
MA (1) MA24473A1 (fr)
NO (1) NO993887L (fr)
NZ (1) NZ337043A (fr)
OA (1) OA11087A (fr)
PL (1) PL334976A1 (fr)
SK (1) SK110299A3 (fr)
TR (1) TR199901961T2 (fr)
WO (1) WO1998035672A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
HUP9901437A3 (en) 1995-09-07 2000-03-28 Smithkline Beecham Plc Pharmaceutical formulation, containing amoxycillin and clavulanate
GB9815532D0 (en) 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
AU2869100A (en) * 1999-02-26 2000-09-14 Biovail International Ltd. Storage stable amoxycillin and clavulanate suspension composition
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
BE1013309A5 (fr) * 1999-04-13 2001-11-06 Beecham Pharm Pte Ltd Formulations pharmaceutiques nouvelles comprenant l'amoxycilline et du clavulanate de potassium.
EP1078627B1 (fr) * 1999-08-20 2006-08-02 Laboratoire GlaxoSmithKline S.A.S. Formulation pharmaceutique comprenant de l'amoxycilline et du clavulanate
FR2797588B1 (fr) * 1999-08-20 2003-08-01 Smithkline Beecham Lab Formulation pharmaceutique a base d'amoxycilline et de clavulanate
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
EP1330236A2 (fr) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
EP1474104A2 (fr) * 2002-02-01 2004-11-10 Sandoz Ag Granulats stables a la segregation
CN1681497A (zh) * 2002-07-16 2005-10-12 兰贝克赛实验室有限公司 口服给药用的可分散片剂
MXPA05013433A (es) * 2003-06-16 2006-03-09 Glaxo Group Ltd Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato.
WO2005123041A1 (fr) * 2004-06-18 2005-12-29 Yuhan Corporation Composition de comprime dispersible administre par voie orale d'amoxycilline et/ou d'acide clavulanique comprenant du bicarbonate de sodium a surface modifiee
SI21912A (sl) * 2004-12-24 2006-06-30 Lek Farmacevtska Druzba D.D. Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN100464750C (zh) * 2006-02-23 2009-03-04 珠海联邦制药股份有限公司 一种制备含阿莫西林钠和克拉维酸钾的药物混合物的方法
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
CA2723409C (fr) 2008-05-09 2016-11-08 Atacama Labs Oy Procede et appareil de granulation par voie seche
CN102861015B (zh) * 2011-07-05 2015-07-08 北京乐维生物技术有限公司 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺
WO2014065769A1 (fr) * 2012-10-22 2014-05-01 Bilgiç Mahmut Formulations pour suspensions orales comprenant des antibiotiques
DK3046548T3 (da) 2013-09-20 2020-04-27 Centrient Pharmaceuticals Netherlands B V Tablet, der omfatter crospovidon
US9254261B2 (en) * 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
MX2022000250A (es) 2019-07-05 2022-02-03 Glaxosmithkline Ip No 2 Ltd Streptomyces clavuligerus.
CN113274357B (zh) * 2021-05-28 2022-12-27 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物及其制备方法
CN114869884A (zh) * 2021-07-30 2022-08-09 江苏恒丰强生物技术有限公司 一种用于猪呼吸道疾病的复方阿莫西林粉及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
EP0680322B1 (fr) * 1993-01-22 2000-07-05 Smithkline Beecham Plc Utilisation de clavulanate et un antibiotique pour le traitement d'infections
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ1926A1 (fr) * 1994-09-03 2002-02-17 Smithkline Beckman P L C Formulations pharmaceutiques.

Also Published As

Publication number Publication date
DE69815833T2 (de) 2004-05-19
TR199901961T2 (xx) 1999-11-22
CN1194687C (zh) 2005-03-30
AP9901623A0 (en) 1999-09-30
AP1253A (en) 2004-03-17
IL131201A0 (en) 2001-01-28
ES2201468T3 (es) 2004-03-16
AU728526B2 (en) 2001-01-11
JP2001512451A (ja) 2001-08-21
KR100499812B1 (ko) 2005-07-08
ATE243516T1 (de) 2003-07-15
EA002595B1 (ru) 2002-06-27
EP0975342A1 (fr) 2000-02-02
AU6719698A (en) 1998-09-08
NO993887D0 (no) 1999-08-12
BG103664A (en) 2000-03-31
CN1251990A (zh) 2000-05-03
BR9807383A (pt) 2000-03-14
PL334976A1 (en) 2000-03-27
NO993887L (no) 1999-08-12
MA24473A1 (fr) 1998-10-01
EA199900647A1 (ru) 2000-06-26
WO1998035672A1 (fr) 1998-08-20
EP1142574A1 (fr) 2001-10-10
HK1043041A1 (zh) 2002-09-06
ID23673A (id) 2000-05-11
DZ2420A1 (fr) 2003-01-04
NZ337043A (en) 2001-02-23
CA2280857A1 (fr) 1998-08-20
KR20000071076A (ko) 2000-11-25
DE69815833D1 (de) 2003-07-31
IL131201A (en) 2005-06-19
EP0975342B1 (fr) 2003-06-25
SK110299A3 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
OA11087A (en) Pharmaceutical formulations comprising amoxocyllinand clavulanate
US6110497A (en) Pharmaceutical formulations
US6756057B2 (en) Amoxicillin and potassium clavulanate dosage form
US20030124187A1 (en) Pharmaceutical formulations comprising amoxycillin and clavulanate
US20040121013A1 (en) Novel formulation
US20040208936A1 (en) Novel compositions
EA001537B1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
US5861172A (en) Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
CZ20011845A3 (cs) Farmaceutické přípravky obsahující cefuroximaxetil
AU769080B2 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
MXPA99007517A (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
CZ288599A3 (cs) Farmaceutický prostředek
SI9200080A (sl) Farmacevtski sestavki, ki vsebujejo stisnjene granulate zdravila